General Information
CONFERENCE INFORMATION
The hybrid Adherence 2022 conference will take place in November 7-9, 2022, at the Mayflower Hotel in Washington, DC, USA. Provided by the International Association of Providers of AIDS Care (IAPAC), in joint partnership with Albert Einstein College of Medicine-Montefiore Medical Center (Einstein-Montefiore), this annual series of conferences features the presentation and discussion of HIV treatment and biomedical prevention adherence research, and current behavioral and clinical perspectives in practicum, within the context of optimizing the continuum of HIV care and prevention.
The conference theme is “Navigating the Future of HIV,” reflecting the need to navigate a course towards regaining lost momentum across global, national, and municipal HIV responses by leveraging innovation. The conference is taking place in Washington, DC, USA, with an ancillary aim of providing critical input to US federal agencies striving to end the HIV epidemic in the United States, as well as US and global health agencies working towards the goal of controlling the HIV epidemic.
The conference will feature a Keynote Address, Memorial Lecture, Memorial Colloquium, five thematic sessions, six oral abstract sessions (including late-breakers), and an e-poster session. Additionally, a pre-conference session will focus on the US Government engagement in the domestic and global AIDS responses.
Click here to view the current Adherence 2022 conference program.
The conference co-chairs are Jane M. Simoni, PhD (University of Washington, Seattle, WA, USA) and Jessica Haberer, MD, MS (Massachusetts General Hospital, Boston, MA, USA). The conference will feature five-tracks.
- HIV Care Continuum
- Implementation Science
- Optimizing ART Adherence
- PrEP Uptake, Adherence, and Persistence
- Community Participatory Engagement
LEARNING OBJECTIVES
Upon successful completion of this activity, learners will be able to:
1. Employ interventions to enhance linkage to and retention in and sustained engagement in HIV care
2. Apply strategies to optimize antiretroviral therapy and pre-exposure prophylaxis adherence
3. Utilize implementation science to inform evidence-based approaches to implement optimized HIV responses
4. Integrate community participatory engagement into clinical practice to support patient-focused care environments
ACCREDITATION
ACCREDITATION STATEMENT
|
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and the International Association of Providers of AIDS Care. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 9.25 Interprofessional Continuing Education (IPCE) credits* for learning and change. *For physicians, this is the number of AMA PRA Category 1 CreditTM awarded. *For non-physicians, this is the number of AMA PRA Category 1 CreditTM designated. |
CREDIT DESIGNATION STATEMENTS
PHYSICIANS
Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 9.25 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
NURSES
Albert Einstein College of Medicine-Montefiore Medical Center designates this activity for 9.25 nursing contact hours. Nurses should claim only credit commensurate with the extent of their participation in the activity.
PHARMACISTS
 |
Albert Einstein College of Medicine-Montefiore Medical Center designates this continuing education activity for 9.25 contact hours (0.925 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number – JA4008224-9999-22-044-L02-P.
Type of Activity: Knowledge-based After completion of the activity and submission of the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days. |
TARGET AUDIENCE
The target audience for the Adherence 2022 conference includes physicians, nurses and nurse-practitioners, pharmacists, psychologists, behavioral scientists, social scientists, public health specialists, epidemiologists, social workers, case managers, peer educators and navigators, and community health workers working in the field of HIV medicine. Because the conference outcomes are intended to influence public policy around global, national, and municipal HIV responses, the conference may also be of interest to policymakers and individuals who wish to advocate as well as enact and implement evidence-informed HIV policies and interventions in their respective communities and countries.
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.
FINANCIAL DISCLOSURE STATEMENT
The “Policy on Identification, Mitigation and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center requires that faculty participating in any CME/CE activity disclose to the audience any relevant relationships with an ineligible company or companies.
* Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to his or her contribution to the activity, will not be permitted to present.
REGISTRATION
Following are key dates for early and standard conference registration, as well as registration rates:
Early Registration Deadline – March 25, 2022- Standard Registration Deadline – September 30, 2022
- Registration Cancellation Deadline (with $100 penalty) – October 7, 2022
| Deadline | September 30, 2022 | N/A | |
| Registration Type | Standard | Late/Onsite | |
| Member (must be current) | $275 | $325 | |
| Non-Member | $300 | $350 | |
| Student or Retired | $200 | $225 | |
| One-Day Only | $150 | $200 |
ABSTRACT SUBMISSION
Following are key dates for abstract submission (with additional information and guidance available by clicking the Abstracts tab on this webpage):
Abstract Submission/Disposition
Abstract Submission Deadline – April 1, 2022Late-Breaker Abstract Submissions – April 25-29, 2022Abstract Disposition Announcements – May 27, 2022- Deadline to Withdraw Abstract/Change Presenting Author – September 30, 2022
HOTEL ACCOMMODATIONS
IAPAC has negotiated a discounted room block for conference attendees. Following is a key date for making hotel room reservations within the discounted room block:
Hotel Accommodations
- Discounted Room Block Reservation Deadline – October 10, 2022
ACKNOWLEDGEMENT
The Adherence 2022 conference is made possible through educational grants and corporate sponsorships as well as individual registration fees. IAPAC acknowledges support from Gilead Sciences and Merck & Co. in the form of educational grants and ViiV Healthcare in the form of corporate sponsorship. Additional grants and sponsorships will be disclosed as they are finalized.
EXHIBITOR AND SPONSORSHIP INFORMATION
The Adherence 2022 conference provides an opportunity to interact with more than 800 delegates in-person and virtually from a variety of practice settings and experiences, including physicians, nurses, pharmacists, psychologists, social workers, community health workers, and patient advocates. There are a limited number of sponsorship opportunities available for this conference. Please contact IAPAC’s Senior Director of Education Jonathon Hess at jhess@iapac.org with any sponsorship-related queries.
Schedule
Monday, November 7, 2022
| Time | Session |
|---|---|
| 9:00 AM - 11:00 AM | Pre-Conference Session
Pushing Forward: How the Ending the HIV Epidemic in the US Initiative is Advancing the Implementation of Research, Prevention, and Care |
| 1:00 PM - 1:15 PM | Welcome Remarks Jessica Haberer, Massachusetts General Hospital, Boston, MA, USA Jane M. Simoni, University of Washington, Seattle, WA, USA José M. Zuniga, IAPAC, Tampa, FL, USA |
| 1:15 PM - 1:45 PM | Keynote Address
Navigating the Future of HIV: The Role of Equity, Innovation, and Solidarity |
| 1:45 PM - 3:00 PM | HIV Care Continuum Engagement Moderators: Dorina Onoya, University of the Witwatersrand, Johannesburg, South Africa Aadia Rana, University of Alabama at Birmingham, AL, USA |
| Adopting Sustainable Innovations for Remote Access to HIV Care
Denise Evans, University of the Witwatersrand, Johannesburg, South Africa | |
| Maintaining Continuity of COVID-19 Pandemic-Related HIV Services
Wendy Armstrong, Emory University, Atlanta, GA, USA | |
| Telehealth Barriers: Overcoming Technology and Privacy Concerns
Jamison Norwood, Vanderbilt University Medical Center, Nashville, TN, USA | |
| 3:00 PM - 4:15 PM | Implementation Science Moderator: Juliet Iwelunmor, Saint Louis University, St. Louis, MO, USA |
| Discontinuation, Suboptimal Adherence, and Re-Initiation of Oral HIV PrEP
Weiming Tang, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA | |
| Social and Physical Environmental Barriers of Long-Acting ARV Adherence
Steve Scroggins, Saint Louis University, St. Louis, MO, USA | |
| PrEP4Youth: Using Crowdsourcing to Facilitate PrEP Implementation
Titilola Gbaja-Biamila, Nigeria Institute of Medical Research, Lagos, Nigeria Ucheoma Nwaozuru, Washington University in St. Louis, St. Louis, MO, USA | |
| 4:15 PM - 4:30 PM | Break |
| 4:30 PM - 5:30 PM | Three Top-Rated Abstracts |
| 5:30 PM | Adjourn |
Tuesday, November 8, 2022
| Time | Session |
|---|---|
| 7:30 AM - 8:45 AM | Breakfast Session
Integrating U=U into Routine HIV and ART Counselling |
| 9:00 AM - 9:30 AM | Memorial Lecture
Innovations in HIV: Applying Past Lessons to Accelerate Uptake of Novel ARVs |
| 9:30 AM - 9:45 AM | Break |
| 9:45 AM - 11:00 AM | Optimizing ART Adherence Moderator: Jean B. Nachega, Stellenbosch University, Stellenbosch, South Africa |
| Optimizing Early ART Uptake and Enhanced Adherence
Susan Graham, University of Washington, Seattle, WA, USA | |
| Optimizing ART Adherence along the Continuum: Execution
John Kinuthia, Kenyatta National Hospital, Nairobi, Kenya | |
| Facilitating Long-Term ART Adherence to Achieve Persistence
Jean B. Nachega, Stellenbosch University, Stellenbosch, South Africa | |
| 11:00 AM - 11:15 AM | Break |
| 11:15 AM - 12:30 PM | Oral Abstract Sessions 1 |
| 12:30 PM - 2:15 PM | Lunch Symposium
Hosted by ViiV Healthcare |
| 2:15 PM - 3:30 PM | Oral Abstract Sessions 2 |
| 3:30 PM - 3:45 PM | Break |
| 3:45 PM - 5:00 PM | PrEP Uptake, Adherence, and Persistence Moderator: Faith Kiruthi, Nairobi City County Health Services, Nairobi, Kenya |
| Mitigating the Effects of Stigma on PrEP Uptake, Adherence, and Persistence
Nicasio Njagi Muriuki, Kamukunji Sub County, Nairobi, Kenya | |
| Beyond Prevention: Integrating PrEP as a Whole-Person Healthcare Approach
Anthony Kiplagat, Nairobi Metropolitan Services, Nairobi, Kenya | |
| Leveraging the Impacts of User-Centered Interventions for PrEP Optimization
Mercy Kamau, Jhpiego, Nairobi, Kenya | |
| 5:00 PM | Adjourn |
Wednesday, November 9, 2022
| Time | Session |
|---|---|
| 9:00 AM - 10:00 AM | Memorial Colloquium
Unequal and Under Threat: A Call to Action Against Inequity in the HIV Response Jesse Milan, AIDS United, Washington, DC, USA Sibongile Nkosi, GNP+, Johannesburg, South Africa |
| 10:00 AM - 11:15 AM | Community Participatory Engagement Moderator: Erika Castellanos, Global Action for Trans Equality, Amsterdam, Netherlands |
| Promoting Choice in HIV Prevention: Pills, Rings, and Injectables
Maxi Jokonya, Y+ Global, Harare, Zimbabwe | |
| Examining and Addressing HIV Dynamics in an Aging Population
Javier Hourcade Bellocq, Communities Delegation, Buenos Aires, Argentina | |
| Defining ‘Communities’ in the Future of the Global HIV Response
Cleiton Euzebio de Lima, UNAIDS, Geneva, Switzerland | |
| 11:15 AM - 11:30 AM | Break |
| 11:30 AM - 12:30 PM | Oral Abstract Sessions 3 |
| 12:30 PM - 2:00 PM | Lunch Symposium
Hosted by Virology Education |
| 2:00 PM -2:15 PM | Break |
| 2:15 PM - 3:15 PM | Oral Abstract Sessions 4 |
| 3:15 PM - 4:15 PM | Late-Breaker Abstracts |
| 4:15 PM - 4:45 PM | Highlights from Adherence 2022: Rapporteur Session |
| 4:45 PM - 5:00 PM | Closing Remarks
Navigating the Future of HIV: What Have We Learned? What Can We Action? |
| 5:00 PM | Adjourn |
Register
Venue and Accommodations
The Adherence 2022 conference venue will be the Mayflower Hotel, which is located at 1127 Connecticut Avenue, NW, Washington, DC, USA, 20036.
The discounted hotel room rate is $249 per night plus tax. Reservations must be made before 6:00 pm ET, Monday, October 10, 2022. Click here to make your reservation online. Call 1-877-212-5752 if you prefer to make your reservation by phone and mention the International Association of Providers of AIDS Care room block.
Submit an Abstract
The Adherence 2022 conference will feature oral abstract and e-poster sessions. The portal is open for submissions through the two timeframes specified below for standard abstract and late-breaker abstract submission. Abstract submissions on data that have already been published in full in a peer-reviewed journal(s) or presented at a major conference (e.g., CROI, IAS/AIDS) are not eligible for submission. However, the conference organizers will accept abstract submissions on data previously or concurrently submitted to other conferences, if permissible by their guidelines.
KEY DATES
Following are key dates relevant to abstract submissions:
Abstract Submission Deadline – April 1, 2022Late-Breaker Abstract Submissions – April 25-29, 2022Abstract Disposition Announcements – May 27, 2022- Deadline to Withdraw Abstract/Change Presenting Author – September 30, 2022
CALL FOR ABSTRACTS
Abstract submissions are encouraged in a wide variety of specific domains, including:
- Antiretroviral therapy medication and medication adherence
- Linkage, retention, and re-engagement in HIV care
- Adherence and engagement in biomedical HIV prevention strategies
- Implementation science related to HIV care continuum optimization
- Community engagement in planning, implementing, and monitoring HIV responses
Within these areas we encourage coverage of:
- Advances in basic science
- Innovative monitoring strategies
- Longitudinal or observational data
- Innovations in modeling and biopsychosocial theory
- Intervention development, implementation, and/or outcomes
- Dissemination/implementation of evidence-based approaches
- Operations research, demonstration projects, and practice-based approaches
- Health care policy and financing at local, state, and national levels
- Resource, structural, and service delivery issues and innovations
- Implementation science design, evidence, and real-world applicability
- Service delivery adaptations and innovations in the context of COVID-19
- Mitigation of HIV service disruption within the context of public health crises
Particularly as applied to key and disproportionately affected populations and settings:
- Treatment naïve, treatment experienced
- Individuals living with mental and/or physical health challenges
- Concomitant diseases (e.g., HBV, HCV, TB)
- Comorbid conditions (e.g., diabetes, hypertension)
- Syndemic conditions (e.g., mental health, substance use)
- Resource-constrained settings and geographies
- Key and vulnerable populations:
- Men who have sex with men
- Transgender individuals
- Women in high HIV incidence areas
- Female and male sex workers
- Pregnant women
- Children and adolescents
- Substance users
- Incarcerated or recently released individuals
- Homeless and/or marginally housed individuals
ABSTRACT SUBMISSION
Abstracts must be submitted online by 5 pm ET, April 1, 2022. Submitted abstracts will be considered for oral or e-poster presentation. Submitted abstracts should report information not previously published, or intended to be published, prior to June 10, 2022.
It is the responsibility of the presenting author to ensure accuracy of content, spelling, and presentation. Abstracts will be published as submitted, subject to reformatting that may be required by IAPAC.
ABSTRACT FORMAT
Abstract contents will be either research-based data using established scientific methods or demonstrate experience and information from individuals or institutions working in the field. Please follow one of two structured formats (A or B), indicating in bold the four parts of your abstract:
Format A: Data-Driven Abstracts
- Background: a concise statement of the issues evaluated
- Methods: the investigational model used
- Results: specific findings
- Conclusions: summary of findings, supported by results
Format B: Program Descriptions and Case Studies
- Introduction: a concise statement of the issues addressed
- Description: a description of the project, case study, experience, or intervention
- Lessons Learned: project results, implementation issues, and/or case study solutions
- Recommendations: further recommendations or next steps
GENERAL GUIDELINES
Following are some general guidelines for individuals interested in submitting an abstract(s):
- The abstract must NOT contain more than 300 words.
- Acceptable abstracts shall contain a concise statement of the research, define the precise subject of the presentation, and be related to the main theme or a sub-theme of the conference.
- Literature references and acknowledgements should not form any part of the abstract’s content.
- Figures and tables are acceptable, subject to high definition/quality guidance to be provided.
- The author is responsible for grammatical and factual details, and may edit an abstract after it has been submitted up to September 30, 2022.
- All abstracts must be submitted in English (without exception).
- Sub-specialty jargon should be avoided, reflecting the interdisciplinary nature of the conference.
- Define all abbreviations and concepts in your abstract at first use.
- For therapeutic agents, only generic names may be used (trade names are not permitted).
ABSTRACT SUBMISSION AND ACCEPTANCE
All abstracts must be submitted online no later than 5:00 pm ET, April 1, 2022. Submissions will be acknowledged upon successful submission via the site. Faxed or mailed abstracts will not be considered.
Please record your abstract number. The number assigned to your abstract when it is submitted online will be the abstract number referenced throughout the conference, including in the Program and Abstracts book, during the Oral Abstract sessions, and during the e-Poster Session. A notice of acceptance or rejection will be sent via e-mail no later than May 27, 2022. The disposition of each abstract will be sent via e-mail only to the submitting author identified on the submission form for that abstract. That contact will be responsible for sharing the disposition with all other authors of the abstract (including the presenting author).
Accepted abstracts will be in one of two categories:
1. Oral Abstract presentation
2. e-Poster Abstract presentation
Presenting authors agree to register for and attend the conference as scheduled in either Oral Abstract sessions or the e-Poster Session. Oral abstract and e-poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees.
Note that only the abstracts of paid conference registrants will be included in the final Program and Abstracts Book. Accepted abstracts will be published in the conference proceedings. Abstracts are considered official communication to IAPAC. Submission of an abstract implies permission to publish abstracts (including in the Journal of the International Association of Providers of AIDS Care [JIAPAC]) and online posting, if accepted. E-posters files must be transferred to IAPAC by June 3, 2022. any electronic presentation and handouts will be transferred to IAPAC.
To reiterate, all abstract submissions must be received online by 5:00 pm ET, April 1, 2022. It is strongly recommended that you do not wait until the last minute to submit your abstract(s). You may review/edit submissions from now until 5:00 pm ET, September 30, 2022. Abstracts may be withdrawn or the presenter may be changed until September 30, 2022.
Call for Nominations
On behalf of the Adherence 2022 conference, and in recognition of the impact the conference delegates are making, IAPAC and the conference Co-Chairs will be presenting two awards to researchers who are making a scientific impact within the field of HIV adherence research.
IAPAC “Rising Star” Award for an Early-Career HIV Adherence Researcher
IAPAC would like to recognize an early career researcher (i.e., within 10 years of their terminal degree) who has already demonstrated expertise and impact in any aspect of HIV adherence research. The recipient will be chosen based on their potential to move the field forward in new and exciting directions.
IAPAC Outstanding Contribution to HIV Adherence Award for a Senior Researcher
IAPAC would like to recognize a senior researcher (i.e., more than 10 years after their terminal degree) who has significantly contributed to the field of HIV adherence, with evidence of scientific impact. The recipient’s mentorship of other investigators also will be considered during the selection process.
Please nominate yourself or another by sending the following information to jhess@iapac.org with the subject line Adherence 2022 Nomination by August 26, 2022:
- Biosketch
- Figures, tables, or graphics are not allowed in the biosketch. Do not embed or attach files (e.g. video, graphics, sound, data).
- The biosketch may not exceed 5 pages per person.
- One letter (max 1 page) describing the nominee’s impact on the field of HIV adherence research; more than one person may contribute to the letter.
